NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
31 March 2025
Name: | OCCUPATIONAL & MEDICAL INNOVATIONS LIMITED (OMI) (This company subsequently changed its name to OVANTI LIMITED. You should refer to that name for Status.) | |||||||||||||||
Date of Listing: | 12 October 2000 | |||||||||||||||
Subsequent Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to OVANTI LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to OVANTI LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now OVANTI LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
FROM | TO | |
OVANTI LIMITED | 07/02/2024 | |
IOUPAY LIMITED | 05/10/2020 | 07/02/2024 |
ISENTRIC LIMITED. | 25/09/2014 | 05/10/2020 |
OMI HOLDINGS LIMITED | 25/08/2010 | 25/09/2014 |
OCCUPATIONAL & MEDICAL INNOVATIONS LIMITED | 25/08/2010 |
Computershare Brisbane
Level 1, 200 Mary Street Brisbane QLD 4000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3229 9860
RegistryWebsite RegistryEmail
Expand this box to read and print
releases Annual Report to shareholders | 25/10/2010 |
the Annual General Meeting of OMI Holdings Limited (subject to Deed of Company Arrangement) will be held at the Bowlers Club, 95 York Street, Sydney, New South Wales, on Thursday, 25 November 2010 at 11.30am | 25/10/2010 |
issues a prospectus for the offer of 60 million shares at a price of $0.0025 per share to raise $150,000 together with 60 million free attaching options exercisable at $0.005 per option on or before 31 December 2013 (Promoter Offer) AND For the offer of 330 million shares at a price of $0.005 per share to raise $1,650,000 (plus oversubscriptions of up to 150 million shares to raise up to a further $750,000) (General Offer) | 27/09/2010 |
name changed to OMI Holdings Limited | 25/08/2010 |
we understand that on or about this date the company consolidated its shares 1 for 5 | 28/07/2010 |
at a general meeting resolutions were passed to consolidate shares (1 for 5), issue new shares, remove directors and elect directors | 26/07/2010 |
releases deed of company arrangement | 08/06/2010 |
Sun Biomedical Limited (ASX Code: SBN)proposes to take an equity position in OMI as part of its recapitalisation | 06/05/2010 |
David Stimpson and Terrence Rose of SV Partners having called a meeting of the top shareholders on 3 February 2010, have failed to provide details of the outcomes to the market as a whole and to the rest of the shareholders | 26/03/2010 |
David Stimpson and Terrence Rose of SV Partners call an informal meeting of the top 20 shareholders - purpose is to provide an update | 25/01/2010 |
David Stimpson and Terrence Rose of SV Partners are appointed as joint and several voluntary administrators of Occupational & Medical Innovations Limited by resolution of the board | 31/12/2009 |
OMI has entered into loan agreements with Chelsea Printing (a company associated with OMI's newly appointed Board member, Mr Mike Brooks) and with other parties who are existing shareholders of OMI. Chelsea Printing has advanced approximately $1,283,000 to OMI, $450,000 of which has been used to repay the loan Chelsea Printing made to OMI, details of which were advised to the market on 6 January 2009. OMI has granted security to Chelsea Printing in relation this new loan. Other existing shareholders have also advanced funds totalling $115,000 to OMI - OMI has obtained litigation funding support from its US lawyers, Howrey LLP. in relation to accounts for fees and expenses already rendered but not yet paid and in relation to accounts for fees and expenses to be rendered going forward in its current US litigation | 21/12/2009 |
advises of the status of court action in the US over certain patent infringement matters | 14/12/2009 |
advises details of the resolutions and the proxies received in respect of each resolution - all were carried as ordinary resolutions on a show of hands | 30/11/2009 |
the Annual General Meeting of Occupational & Medical Innovations Limited will be held at the offices of McCullough Robertson, Level 11 Central Plaza Two, 66 Eagle Street, Brisbane, Queensland, 4000 on Monday 30 November 2009 at 9.00am | 02/11/2009 |
the Auditors of OMI have expressed the opinion that the company's financial report does not give a "true and fair" view of the company's financial position and that the financial report does not comply with the relevant Australian Accounting Standards and International Financial Reporting Standards - this audit opinion results from the Auditors deciding there was "insufficient appropriate audit evidence" to support the Board's decision to accept the Full Year Accounts as properly prepared on a "going concern" basis - ASX has decided that, at this stage, it is not appropriate to re-admit OMI shares to trading - the company held discussions with ASX on 9 October 2009 and understands that the primary reason for ASX's current position regarding re-admission of OMI shares to trading is the adverse audit opinion regarding the Full Year Accounts - OMI will keep the market appropriately informed of all relevant developments | 12/10/2009 |
releases Annual Report to shareholders | 08/10/2009 |
securities suspended from quotation following failure to lodge full year accounts | 01/10/2009 |
shares suspended from quotation following failure to lodge half year report and accounts | 01/09/2009 |
the suspension of trading in the securities of Occupational and Medical Innovations Limited (the "Company") will be lifted before the commencement of trading on Wednesday, 2 September 2009 in accordance with listing rule 17.8, following receipt of the Company's Preliminary Final Report for the period ended 30 June 2009 | 01/09/2009 |
listed entity carried for record purposes only | 01/07/2004 |
releases Annual Report to shareholders | 25/10/2010 |
the Annual General Meeting of OMI Holdings Limited (subject to Deed of Company Arrangement) will be held at the Bowlers Club, 95 York Street, Sydney, New South Wales, on Thursday, 25 November 2010 at 11.30am | 25/10/2010 |
issues a prospectus for the offer of 60 million shares at a price of $0.0025 per share to raise $150,000 together with 60 million free attaching options exercisable at $0.005 per option on or before 31 December 2013 (Promoter Offer) AND For the offer of 330 million shares at a price of $0.005 per share to raise $1,650,000 (plus oversubscriptions of up to 150 million shares to raise up to a further $750,000) (General Offer) | 27/09/2010 |
name changed to OMI Holdings Limited | 25/08/2010 |
we understand that on or about this date the company consolidated its shares 1 for 5 | 28/07/2010 |
at a general meeting resolutions were passed to consolidate shares (1 for 5), issue new shares, remove directors and elect directors | 26/07/2010 |
releases deed of company arrangement | 08/06/2010 |
Sun Biomedical Limited (ASX Code: SBN)proposes to take an equity position in OMI as part of its recapitalisation | 06/05/2010 |
David Stimpson and Terrence Rose of SV Partners having called a meeting of the top shareholders on 3 February 2010, have failed to provide details of the outcomes to the market as a whole and to the rest of the shareholders | 26/03/2010 |
David Stimpson and Terrence Rose of SV Partners call an informal meeting of the top 20 shareholders - purpose is to provide an update | 25/01/2010 |
David Stimpson and Terrence Rose of SV Partners are appointed as joint and several voluntary administrators of Occupational & Medical Innovations Limited by resolution of the board | 31/12/2009 |
OMI has entered into loan agreements with Chelsea Printing (a company associated with OMI's newly appointed Board member, Mr Mike Brooks) and with other parties who are existing shareholders of OMI. Chelsea Printing has advanced approximately $1,283,000 to OMI, $450,000 of which has been used to repay the loan Chelsea Printing made to OMI, details of which were advised to the market on 6 January 2009. OMI has granted security to Chelsea Printing in relation this new loan. Other existing shareholders have also advanced funds totalling $115,000 to OMI - OMI has obtained litigation funding support from its US lawyers, Howrey LLP. in relation to accounts for fees and expenses already rendered but not yet paid and in relation to accounts for fees and expenses to be rendered going forward in its current US litigation | 21/12/2009 |
advises of the status of court action in the US over certain patent infringement matters | 14/12/2009 |
advises details of the resolutions and the proxies received in respect of each resolution - all were carried as ordinary resolutions on a show of hands | 30/11/2009 |
the Annual General Meeting of Occupational & Medical Innovations Limited will be held at the offices of McCullough Robertson, Level 11 Central Plaza Two, 66 Eagle Street, Brisbane, Queensland, 4000 on Monday 30 November 2009 at 9.00am | 02/11/2009 |
the Auditors of OMI have expressed the opinion that the company's financial report does not give a "true and fair" view of the company's financial position and that the financial report does not comply with the relevant Australian Accounting Standards and International Financial Reporting Standards - this audit opinion results from the Auditors deciding there was "insufficient appropriate audit evidence" to support the Board's decision to accept the Full Year Accounts as properly prepared on a "going concern" basis - ASX has decided that, at this stage, it is not appropriate to re-admit OMI shares to trading - the company held discussions with ASX on 9 October 2009 and understands that the primary reason for ASX's current position regarding re-admission of OMI shares to trading is the adverse audit opinion regarding the Full Year Accounts - OMI will keep the market appropriately informed of all relevant developments | 12/10/2009 |
releases Annual Report to shareholders | 08/10/2009 |
securities suspended from quotation following failure to lodge full year accounts | 01/10/2009 |
shares suspended from quotation following failure to lodge half year report and accounts | 01/09/2009 |
the suspension of trading in the securities of Occupational and Medical Innovations Limited (the "Company") will be lifted before the commencement of trading on Wednesday, 2 September 2009 in accordance with listing rule 17.8, following receipt of the Company's Preliminary Final Report for the period ended 30 June 2009 | 01/09/2009 |
listed entity carried for record purposes only | 01/07/2004 |
Your browser may reflect a date of printing in American format.
NAME | TITLE | DATE OF APPT |
---|---|---|
Ian Fraser | Executive Chairman | |
Donald Mackenzie | Director | |
Alistair Cray | Director | |
David Shirley | Director | |
Bruce Kiehne | Director | |
Phillip MacLeod | Company Secretary |
Date of first appointment, title may have changed.
NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
---|
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.